SteelPeak Wealth LLC purchased a new position in shares of Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 668 shares of the biotechnology company’s stock, valued at approximately $209,000.
Other institutional investors have also modified their holdings of the company. Trivant Custom Portfolio Group LLC acquired a new stake in Axon Enterprise during the first quarter worth about $31,000. Hennion & Walsh Asset Management Inc. purchased a new position in shares of Axon Enterprise during the 1st quarter valued at approximately $392,000. AMF Tjanstepension AB lifted its stake in shares of Axon Enterprise by 26.7% in the 1st quarter. AMF Tjanstepension AB now owns 34,341 shares of the biotechnology company’s stock valued at $10,745,000 after purchasing an additional 7,233 shares during the period. Wealth Enhancement Advisory Services LLC grew its position in Axon Enterprise by 4.4% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 7,519 shares of the biotechnology company’s stock valued at $2,353,000 after buying an additional 319 shares during the period. Finally, Brookstone Capital Management increased its holdings in Axon Enterprise by 5.1% in the first quarter. Brookstone Capital Management now owns 839 shares of the biotechnology company’s stock valued at $263,000 after buying an additional 41 shares in the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.
Insider Buying and Selling
In other news, Director Jeri Williams sold 308 shares of the company’s stock in a transaction on Thursday, May 9th. The stock was sold at an average price of $310.07, for a total value of $95,501.56. Following the transaction, the director now owns 1,607 shares of the company’s stock, valued at approximately $498,282.49. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In other news, Director Jeri Williams sold 308 shares of the company’s stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $310.07, for a total value of $95,501.56. Following the transaction, the director now directly owns 1,607 shares in the company, valued at approximately $498,282.49. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Julie A. Cullivan sold 478 shares of Axon Enterprise stock in a transaction that occurred on Tuesday, May 28th. The shares were sold at an average price of $286.04, for a total transaction of $136,727.12. Following the completion of the sale, the director now owns 5,546 shares of the company’s stock, valued at approximately $1,586,377.84. The disclosure for this sale can be found here. Over the last three months, insiders sold 89,447 shares of company stock worth $27,684,677. Company insiders own 5.70% of the company’s stock.
Wall Street Analysts Forecast Growth
Read Our Latest Analysis on Axon Enterprise
Axon Enterprise Stock Down 1.4 %
Shares of NASDAQ:AXON opened at $294.24 on Monday. Axon Enterprise, Inc. has a 52-week low of $175.37 and a 52-week high of $329.87. The stock has a market cap of $22.21 billion, a P/E ratio of 86.04 and a beta of 0.95. The business has a fifty day moving average of $295.25 and a two-hundred day moving average of $285.26. The company has a quick ratio of 2.55, a current ratio of 2.91 and a debt-to-equity ratio of 0.37.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last released its quarterly earnings data on Friday, May 10th. The biotechnology company reported $1.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.95 by $0.20. Axon Enterprise had a net margin of 15.60% and a return on equity of 11.71%. The firm had revenue of $460.74 million during the quarter, compared to analysts’ expectations of $441.57 million. During the same period last year, the business earned $0.51 earnings per share. Axon Enterprise’s revenue was up 34.3% compared to the same quarter last year. On average, research analysts expect that Axon Enterprise, Inc. will post 2.35 earnings per share for the current year.
About Axon Enterprise
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Featured Stories
- Five stocks we like better than Axon Enterprise
- Election Stocks: How Elections Affect the Stock Market
- 3 Stocks Upgraded by Analysts: Home Depot, U.S. Steel, Alcoa
- What is the Euro STOXX 50 Index?
- NVIDIA and TSM Stock: Is Semiconductor Sector Momentum Slowing?
- What is a Death Cross in Stocks?
- Palo Alto Networks Stock Gains AI-Powered Cybersecurity Solutions
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.